We are live on ! Find out more
OPK icon

Opko Health

200 hedge funds and large institutions have $377M invested in Opko Health in 2019 Q2 according to their latest regulatory filings, with 26 funds opening new positions, 56 increasing their positions, 56 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

8% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 24

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

0% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 56

0% less funds holding

Funds holding: 201200 (-1)

0.81% less ownership

Funds ownership: 25.92%25.11% (-0.81%)

10% less capital invested

Capital invested by funds: $418M → $377M (-$41.4M)

45% less call options, than puts

Call options by funds: $5.45M | Put options by funds: $9.84M

Holders
200
Holders Change
-1
Holders Change %
-0.5%
% of All Funds
4.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
26
Increased
56
Reduced
56
Closed
24
Calls
$5.45M
Puts
$9.84M
Net Calls
-$4.39M
Net Calls Change
+$13.8M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$76.9M +$2.9M +1,330,639 +4%
Vanguard Group
2
Vanguard Group
Pennsylvania
$74.3M +$1.77M +812,237 +3%
State Street
3
State Street
Massachusetts
$44.9M -$3.75M -1,719,442 -9%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$12.6M +$1.41M +644,561 +14%
Dimensional Fund Advisors
5
Dimensional Fund Advisors
Texas
$11.1M +$512K +234,610 +5%
Northern Trust
6
Northern Trust
Illinois
$10.2M +$382K +175,185 +4%
OIM
7
Oracle Investment Management
Connecticut
$8.99M
Norges Bank
8
Norges Bank
Norway
$8.12M
Charles Schwab
9
Charles Schwab
California
$5.83M +$280K +128,250 +6%
Goldman Sachs
10
Goldman Sachs
New York
$5.42M +$1.3M +598,122 +37%
Millennium Management
11
Millennium Management
New York
$5.31M +$2.09M +959,503 +79%
MTWSIF
12
Mivtachim The Workers Social Insurance Fund
Israel
$5.11M +$2.26M +1,037,669 +98%
PAM
13
Panagora Asset Management
Massachusetts
$4.8M -$380K -174,329 -8%
N
14
Nuveen
North Carolina
$4.79M +$4.28M +1,962,587 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$4.27M +$170K +77,966 +5%
Morgan Stanley
16
Morgan Stanley
New York
$4.15M -$3.64M -1,670,080 -50%
Bank of America
17
Bank of America
North Carolina
$4.04M -$1.07M -489,506 -23%
ACM
18
Asymmetry Capital Management
California
$3.97M +$3.55M +1,628,666 New
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$3.74M -$404K -185,036 -11%
Wells Fargo
20
Wells Fargo
California
$3.6M -$45.5K -20,868 -1%
IECM
21
Intrinsic Edge Capital Management
Illinois
$3.03M +$2.71M +1,240,000 New
RAM
22
RK Asset Management
Michigan
$2.88M
Susquehanna International Group
23
Susquehanna International Group
Pennsylvania
$2.82M +$648K +296,926 +35%
Citigroup
24
Citigroup
New York
$2.7M +$2.16M +990,316 +857%
Two Sigma Investments
25
Two Sigma Investments
New York
$2.25M +$1.43M +656,802 +249%

OPK Hedge Fund Activity: Q2 2019 in Review

200 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Opko Health (OPK) for Q2 2019, worth a combined $377M — down 9.9% from $418M a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new OPK positions and 24 closed out — a net gain of 2 holders — while 56 added to existing stakes and 56 trimmed.

The largest buyer was Nuveen, opening a new position worth an estimated $4.28M. The largest seller was Invesco, cutting an estimated $5.94M.

  • 200 institutional investors held Opko Health (OPK) as of Q2 2019, down from 201 in Q1 2019.
  • Funds reported $377M of Opko Health stock for Q2 2019, down 9.9% quarter-over-quarter.
  • 26 funds opened new Opko Health positions in Q2 2019 and 24 closed out, a net change of +2 holders.
  • The largest Opko Health buyer in Q2 2019 was Nuveen, an estimated $4.28M added.
  • The largest Opko Health seller in Q2 2019 was Invesco, an estimated $5.94M sold.

Based on aggregated 13F filings for Q2 2019.